STOCK TITAN

CEMTREX INC (CETXP) SEC Filings, Sep 2025-Mar 2026

CETXP OTC
Rhea-AI Summary

Cemtrex Inc. filed an amended current report to add detailed financial statements and proforma information for its acquisition of Invocon Inc.. Cemtrex completed the deal on January 8, 2026, acquiring 100% of Invocon for $7,060,000 in cash, largely funded with new debt.

Invocon generated $3,783,978 in revenue and a net loss of $310,539 for the year ended December 31, 2024, then improved to revenue of $4,382,819 and net income of $647,551 for the nine months ended September 30, 2025. Proforma, the combined company would have had revenue of $81,764,777 and a net loss attributable to Cemtrex shareholders of $29,347,873 for the year ended September 30, 2025, reflecting added interest expense from the acquisition financing and preliminary goodwill recognition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cemtrex, Inc. announced that its Board of Directors has approved paying the upcoming dividend on its Series 1 Preferred Stock in additional shares of Series 1 Preferred Stock rather than in cash. The dividend will be issued on April 7, 2026 to holders of record at the close of business on March 31, 2026.

Holders of the Series 1 Preferred Stock are entitled to receive dividends at a rate of 10% annually, based on the $10.00 per share preference amount, with payments made on a semiannual schedule. Using stock to satisfy this dividend preserves cash while still honoring the stated preferred dividend terms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cemtrex, Inc. approved a reverse stock split. The Board and holders by majority written consent authorized a reverse split at a ratio between 1-for-3 and 1-for-50, with the Board able to set the exact whole-number ratio at any time within 12 months after the consent.

The approval was by written consent on February 27, 2026 for holders of record as of March 6, 2026. As of that record date, 10,078,089 shares of Common Stock were outstanding; the total voting power eligible was 116,513,398 votes, and holders representing 101,219,376 votes (approximately 86.87%) voted in favor. The Board retains discretion whether and when to file the Certificate of Amendment to effect the Reverse Split and may abandon it prior to filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
Rhea-AI Summary

Cemtrex, Inc. reported a larger-than-normal quarterly loss despite higher sales. For the three months ended December 31, 2025, revenue rose to $16.1 million from $13.7 million, but net loss was still $20.6 million, driven mainly by $12.1 million of interest expense and $4.7 million of warrant-related losses.

Cash and cash equivalents increased sharply to $20.5 million, helped by $5.7 million of warrant exercises, $6.0 million of equity offerings, and a $7.0 million note. Common shares outstanding jumped to 8.6 million at December 31, 2025, and 10.1 million by February 13, 2026, reflecting significant dilution.

Management explicitly states that recurring losses of $28.1 million in fiscal 2025, a $20.6 million quarterly loss, and $6.7 million of debt due within a year raise substantial doubt about Cemtrex’s ability to continue as a going concern. Subsequent to quarter-end, Cemtrex completed a $7.06 million cash acquisition of Invocon and a Tennessee industrial services acquisition funded with new bank debt and a $4.9 million mortgage.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.59%
Tags
quarterly report
-
Rhea-AI Summary

Cemtrex Inc. investors reported a significant ownership position in the company’s common stock. As of the close of business on December 31, 2025, the reporting persons may be deemed to beneficially own 605,011 shares of common stock issuable upon exercise of a warrant, representing approximately 7.3% of the class.

This percentage is based on 7,711,663 shares of common stock outstanding as of December 29, 2025, plus the warrant shares. The position is held through Intracoastal Capital LLC and attributed to Mitchell P. Kopin and Daniel B. Asher, who share voting and dispositive power and certify the holding is not for changing control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Cemtrex, Inc., through its Advanced Industrial Services subsidiary, completed the acquisition of substantially all assets of Richland Industries in Tennessee and bought its main operating facility. AIS paid $600,000 for the business assets and $4,900,000 for the Pulaski facility.

The business asset purchase was financed with a Fulton Bank note at 6.09% interest maturing February 1, 2031. The real estate purchase was funded with a $3,920,000 Fulton Bank mortgage at SOFR plus 2.75% maturing February 1, 2041, plus cash for the remaining price and closing costs.

Richland’s operations are being integrated into Cemtrex’s Industrial Services segment via new subsidiary AIS Tennessee. Based on historical performance and current backlog, AIS Tennessee is expected to contribute approximately $8 to $10M in revenue over the next twelve months, expanding AIS’s presence in the Southeastern U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Cemtrex Inc. reported that its board of directors approved payment of the upcoming dividend on its Series 1 Preferred Stock in additional shares of the same Series 1 Preferred Stock rather than in cash. The new shares are expected to be issued on October 7, 2025 to holders of record as of the close of business on September 30, 2025.

Holders of the Series 1 Preferred Stock are entitled to receive dividends at a 10% annual rate, based on a $10.00 per share preference amount, with dividends payable on a semiannual schedule.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

How many CEMTREX (CETXP) SEC filings are available on StockTitan?

StockTitan tracks 17 SEC filings for CEMTREX (CETXP), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for CEMTREX (CETXP)?

The most recent SEC filing for CEMTREX (CETXP) was filed on March 24, 2026.